Rockwell Medical Technologies, Inc.

Rockwell Medical Technologies, Inc. engages in the manufacture, sale, and distribution of hemodialysis concentrate solutions and dialysis kits primarily to hemodialysis providers in the United States, Latin America, Asia, and Europe. Its products are used to cleanse patient’s blood and replace nutrients during the kidney dialysis process. The company’s hemodialysis concentrates include acid concentrates consisting of sodium chloride, dextrose, and electrolyte additives, such as magnesium, potassium, and calcium; Dri-Sate dry acid concentrate; bicarbonate products; and SteriLyte liquid bicarbonate that is used in acute care and chronic care settings. Rockwell also offers a range of ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. In addition, the company manufactures and sells iron supplemented dialysate, which is used for the treatment of dialysis patients with iron deficiency that is pervasive in the dialysis patient population. Rockwell was founded in 1995 and is based in Wixom, Michigan.